The prevalence of non-alcoholic fatty liver disease (NAFLD) an NASH, are of the most common liver diseases, and the prevalence is rising. About 25% of adults worldwide are probably affected by N A F L D. This program explores the NAFLD and NASH diagnosis and treatment options for patients.